Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial
- DOI
- 10.1016/j.eclinm.2022.101432
- Published
- 2022-06
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2022.101432,
title = {Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial},
author = {Dean A. Fennell and Catharine Porter and Jason Lester and Sarah Danson and Paul Taylor and Michael Sheaff and Robin M Rudd and Aarti Gaba and Sara Busacca and Lisette Nixon and Georgina Gardner and Liz Darlison and Charlotte Poile and Cathy Richards and Peter-Wells Jordan and Gareth Griffiths and Angela Casbard},
year = {2022},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2022.101432},
url = {https://doi.org/10.1016/j.eclinm.2022.101432}
}RIS
TY - JOUR TI - Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial AU - Dean A. Fennell AU - Catharine Porter AU - Jason Lester AU - Sarah Danson AU - Paul Taylor AU - Michael Sheaff AU - Robin M Rudd AU - Aarti Gaba AU - Sara Busacca AU - Lisette Nixon AU - Georgina Gardner AU - Liz Darlison AU - Charlotte Poile AU - Cathy Richards AU - Peter-Wells Jordan AU - Gareth Griffiths AU - Angela Casbard PY - 2022 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2022.101432 UR - https://doi.org/10.1016/j.eclinm.2022.101432 ER -
APA
Fennell, D. A., Porter, C., Lester, J., Danson, S., Taylor, P., Sheaff, M., Rudd, R. M., Gaba, A., Busacca, S., Nixon, L., Gardner, G., Darlison, L., Poile, C., Richards, C., Jordan, P., Griffiths, G., & Casbard, A. (2022). Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101432
Source records
- crossref · retrieved 2026-09-25T21:44:26.915Z